Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety of Olanzapine in Subjects With Major Depression”

2 trials

Showing 2 of 2 results

Testing effectiveness (Phase 2)Study completedNCT01282632
What this trial is testing

Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression

Who this might be right for
Subjects Had Unipolar, Non-psychotic Major Depression
Sunnybrook Health Sciences Centre 42
Large-scale testing (Phase 3)WithdrawnNCT00568672
What this trial is testing

Optimal Duration of Olanzapine Add-on Therapy in Major Depression

Who this might be right for
Relapse Rate of a Major Depressive EpisodeSafety of Olanzapine in Subjects With Major Depression
Charite University, Berlin, Germany

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation